Form 8-K - Current report:
SEC Accession No. 0001640334-23-001207
Filing Date
2023-07-03
Accepted
2023-07-03 14:15:01
Documents
14
Period of Report
2023-06-30
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K artl_8k.htm   iXBRL 8-K 49162
  Complete submission text file 0001640334-23-001207.txt   192614

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA artl-20230630.xsd EX-101.SCH 5970
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE artl-20230630_lab.xml EX-101.LAB 16805
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE artl-20230630_cal.xml EX-101.CAL 908
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE artl-20230630_pre.xml EX-101.PRE 12331
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE artl-20230630_def.xml EX-101.DEF 4204
8 EXTRACTED XBRL INSTANCE DOCUMENT artl_8k_htm.xml XML 5423
Mailing Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075
Business Address 505 LOMAS SANTA FE, SUITE 160 SOLANA BEACH CA 92075 858-925-7049
ARTELO BIOSCIENCES, INC. (Filer) CIK: 0001621221 (see all company filings)

EIN.: 331220924 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38951 | Film No.: 231064737
SIC: 2834 Pharmaceutical Preparations